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Antibody screening tests are critical tools to identify
individuals infected with HTLV-1 and HTLV-2. How-
ever, the lack of reference panels hinders the ability to
evaluate existing tests and new technologies that aid in
the screening for these agents. For example, some
HTLV-2 subtypes may escape detection by currently
available technology. The World Health Organization,
through the support of the WHO Expert Committee on
Biological Standardization, is in the process of generat-
ing such a reference panel.
This reference panel will best function as a tool for
test assessment only if it consists of specimens repre-
senting the diversity of HTLV-1 and HTLV-2, especially
those subtypes known to present challenges to detection
using serological tests. A panel consisting of seven
members (HTLV-1a-d and HTLV-2a,b,d) is being
considered.
The reference panel will be fully characterised and
assessed in an international collaborative study. This
first WHO HTLV antibody reference panel is expected
to be used by blood screening and diagnostic test devel-
opers, blood banks, hospitals and other establishments
performing HTLV serology testing.
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